CClinicalTrials.gg
Status unknownNCT02349581PPBCSUpdated Jan 29, 2015

Ultrasound Guided Pectoral Nerves Blockade for Persistent Pain After Breast Cancer Surgery

A Phase 2 interventional study of PECS block and Bupivacaine in Persistent Pain After Breast Cancer Surgery, sponsored by Rigshospitalet, Denmark. Status unknown at 1 site in Denmark. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-01-29.

Sponsored by Rigshospitalet, Denmark · Phase 2, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jan 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
6
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This is a pilot study of the pectoral nerves block (PECS) in patients with persistent pain after breast cancer surgery.

Read the detailed description

This study is in 2 parts: Part 1 is a description of the anatomy of the PECS block in pain free, unoperated patients using ultrasonography (non invasive). Part 2 is the administration of the block to patients that have persistent pain after breast cancer surgery. Before and after the block we will take a detailed pain history and do neurophysiological tests called quantitative sensory testing (QST). These tests assess the patients' ability to feel warmth, cold and test their thresholds for pain. The block is then administered using ultrasound guidance and 20mls of 0.25% bupivacaine is injected in the pectoral muscles on the side with pain. Thirty minutes after the block, the pain is re assessed and the QST is repeated.

02

Conditions studied

  • Persistent Pain After Breast Cancer Surgery

Browse trials for

Keywords

  • Anesthetics, Local
  • Mastectomy
  • Neuralgia
  • Nerve block
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 6 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female patients, aged 18 years or over, treated for breast cancer
  • Patients with persistent pain in the breast after surgical treatment for breast cancer. Their pain score must be 4 or more on the numerical rating scale (NRS).

Exclusion criteria

Exclusion Criteria:

  • breast surgery within the last 12 months
  • previous cosmetic surgery
  • bilateral breast cancer (receiving bilateral intervention)
  • pregnant or breast feeding
  • neurological disease
  • on-going treatment for severe mental illness or who abuse alcohol or drugs
  • are unable to understand written or spoken Danish or English
  • lack mental capacity to give informed consent or cooperate with the neurophysiological testing
  • an allergy to amide local anaesthetics
  • pacemaker in situ
  • received treatment outside guidelines and recommendations from the Danish Breast Cancer Co-operative Group (DBCG)
05

Study design

Phase
Phase 2
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (estimated)

Study arms

  • Experimental
    Block

    Patients with persistent pain after breast cancer surgery receive the ultrasound guided PECS block of 20mls 0.25% bupivacaine

    Procedure: PECS block · Drug: Bupivacaine

  • No intervention
    Sonoanatomy

    16 patients awaiting surgery for breast cancer were scanned using ultrasound to determine the sonoanatomy of the PECS block

Interventions

  • ProcedurePECS block

    Ultrasound guided delivery of local anesthetic between the pectoral muscles

  • DrugBupivacaine
06

What researchers measure

Primary outcomes

  1. Differences in summed pain intensity score (SPI)

    SPI is a combination of pain at rest + pain on arm abduction + pain with 100kPa pressure. SPI will be taken before and 30 minutes after the PECS block

    Time frame: 30 minutes after blockade

Secondary outcomes

  1. Differences in quantitative sensory testing (QST) values

    QST consists of sensory mapping (delineating areas of hypo/hyperesthesia and/or allodynia), warm detection thresholds, cool detection thresholds, heat pain thresholds, suprathermal heat pain response and pressure pain thresholds. These will be measured before and 30 minutes after the PECS block

    Time frame: 30 minutes after blockade

Other outcomes

  1. Longer term effects (Daily pain scores and functional questionnaire)

    Patients will complete a pain diary for 5 consecutive days before administration of the PECS block and 7 consecutive days after the block. The patients also complete a functional questionnaire the day before the block and again exactly one week after the block.

    Time frame: 1 week after blockade

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02349581
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Kehlet, Henrik, M.D., Ph.D.
Responsible party
Nelun Wijayasinghe (Anesthesiologist, clinical researcher, Rigshospitalet, Denmark) — Principal investigator
First posted
Jan 29, 2015
Start date
Nov 2014
Primary completion
May 2015 (estimated)
Last update
Jan 29, 2015

Study contacts

Nelun Wijayasinghe, MBBS, BSc
Contact
nelun.wijayasinghe@regionh.dk
+45 35456643
Kenneth G Andersen, MD, PhD
Contact
kenneth.geving.andersen@rh.regionh.dk
+45 35 45 66 43
Henrik Kehlet, MD, PhD, DMsc
study director · Rigshospitalet, Denmark

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion